TIDMHELD
RNS Number : 8951N
Hellenic Dynamics PLC
26 January 2023
26 January 2023
Hellenic Dynamics plc
("Hellenic Dynamics" or the "Company")
Appointment of Carl Haffner to Medical Cannabis Cultivation
Team
London, 26 January 2023: Hellenic Dynamics plc (LSE: HELD) is
pleased to announce the appointment of Carl Haffner as part of
Hellenic Dynamics' development team. Carl is an industry expert
having been the Co-founder and Chief Operations Officer of UK firm
Avida Global Ltd and Chief Executive Officer of Colombian based
Avida Global SAS, a vertically integrated cannabis business.
Starting from a greenfield site, Avida Global went on to create
a large-scale medical cannabis cultivation and extraction facility
in Colombia achieving all necessary certifications including ISO,
GACP & EU-GMP.
Carl left Avida Global in September 2022 and has remained active
in the industry as a medical cannabis consultant.
Hellenic Dynamics is a medical cannabis cultivator specifically
focused on the cultivation and supply of tetrahydrocannabinol ("
THC") dominant strains of medical cannabis flowers destined for the
rapidly growing medical cannabis markets across Europe. In December
2022, Hellenic Dynamics became the first medical cannabis
cultivator to list on the London Stock Exchange's main market for
listed securities.
Davinder Rai, CEO of Hellenic Dynamics, commented:
"As a seasoned medical cannabis industry expert I am delighted
that Carl has joined our team. Having previously successfully
established an EU-GMP cultivation facility, his appointment will
provide additional support to ensure our targets are met."
Carl Haffner, commented:
"I am delighted to become part of the Hellenic Dynamics team and
am excited by the prospects of establishing, in Greece, what could
become one of Europe's leading large-scale medical cannabis
cultivation facilities."
The Directors of the Company accept responsibility for the
content of this announcement.
Enquires:
Hellenic Dynamics plc +44 (0)20 3818 7850
Davinder Rai davinder@hellenicdynamics.com
Cairn Financial Advisers LLP
Emily Staples / Jo Turner +44 (0)20 7213 0880
Peterhouse Capital
Lucy Williams / Charles Goodfellow +44 (0)20 7469 0930
J&H Communications
George Hudson +44 (0)7803 603130
About Hellenic Dynamics plc
Founded in 2019, Hellenic Dynamics is specifically focused on
the cultivation and supply of THC ("tetrahydrocannabinol") -
dominant strains of medical cannabis flowers, destined for the
growing medical cannabis markets across Europe. Hellenic Dynamics'
core strategy is to develop and operate its 40,000 square metre
active cultivation licence from its 195,506 square metre facility
located near Thessaloniki in Northern Greece. In full production,
Hellenic Dynamics is capable of producing over 54,000 kg of dried
flowers per annum.
Hellenic Dynamics will take advantage of its relatively low cost
base resulting from a comparatively low cost of power, having its
own running water supply and the labour rates for skilled and
semi-skilled labour in Northern Greece.
25 European countries now allow medical cannabis via
prescription and the European cannabis market is expected to reach
EUR43.3 billion per annum by 2027. Sales of Hellenic Dynamics'
dried THC-dominant cannabis flowers and extracts are initially
intended for export into Europe's largest market - Germany, in
addition to other European markets including domestically in
Greece.
As the first medical cannabis cultivator to obtain a listing on
the main market for listed securities of the London Stock Exchange,
Hellenic is significantly different to the number of CBD
(Cannabidiol) related companies that have appeared over the recent
years. Hellenic Dynamics cultivates THC-dominant medical cannabis
flowers. THC-dominant medical cannabis products are only available
via a medical prescription. Medicinal cannabis has been approved
for use both in the United Kingdom and Germany, plus 23 other
European countries, for conditions including but not limited to
chronic pain, intractable chemotherapy-related nausea, anxiety,
insomnia, Tourette's syndrome, substance use disorder, multiple
sclerosis, IBS, spinal cord treatment, lack of appetite due to
HIV/AIDS, cachexia, anorexia and glaucoma.
For further information please visit our website
www.hellenicdynamics.com
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed
to be, forward looking statements. Forward looking statements are
identi ed by their use of terms and phrases such as "believe",
"could", "should" "envisage", "estimate", "intend", "may", "plan",
"potentially", "expect", "will" or the negative of those,
variations or comparable expressions, including references to
assumptions. These forward-looking statements are not based on
historical facts but rather on the Directors' current expectations
and assumptions regarding the Company's future growth, results of
operations, performance, future capital and other expenditures
(including the amount, nature and sources of funding thereof),
competitive advantages, business prospects and opportunities. Such
forward looking statements re ect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCPPUAGGUPWPUA
(END) Dow Jones Newswires
January 26, 2023 02:00 ET (07:00 GMT)
U.k. Spac (LSE:SPC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
U.k. Spac (LSE:SPC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
